Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.77−0.04 (-5.03%)
Close on Nov 13, 2026Market cap $8.96MP/E –Yield –
Phio Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Phio Pharmaceuticals's price to sales ratio was 60.9× on Apr 30, 2020, against 66.9× a year earlier. Over the last 4 years it ranged from 9.6× to 471.2×, with a median of 103.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Apr 30, 2020 | 60.9× | −148.1 |
| 2019 | Dec 31, 2019 | 208.9× | +199.3 |
| 2018 | Dec 31, 2018 | 9.6× | −432.9 |
| 2017 | Apr 28, 2017 | 442.5× | +194.4 |
| 2016 | Dec 30, 2016 | 248.1× | +174.0 |
| 2014 | Oct 31, 2014 | 74.1× | −273.1 |
| 2013 | Apr 30, 2013 | 347.2× | – |
See a number that looks wrong?